Carotid Artery Stenosis
1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Providence TherapeuticsAB - Calgary
1 program1
Carotid Stent with Distal Protection DevicePhase 31 trial
Active Trials
Contego MedicalNC - Raleigh
1 programCarotid artery stenting with Neuroguard IEP SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Providence TherapeuticsCarotid Stent with Distal Protection Device
CordisPRECISE PRO Rx Nitinol Stent System
Contego MedicalCarotid artery stenting with Neuroguard IEP System
AbbottEmboshield NAV6® embolic protection system
Clinical Trials (4)
Total enrollment: 279 patients across 4 trials
Carotid Artery Stenting With Protection Registry
Start: Sep 2003Est. completion: Aug 2007
Phase 3Completed
PMCF Study of Precise Pro Rx for Carotid Artery Disease
Start: Oct 2025Est. completion: Feb 2026199 patients
N/ACompleted
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Start: Jun 2020Est. completion: Dec 2025
N/AActive Not Recruiting
Impact of Aspiration Thrombectomy During Carotid Stenting
Start: Feb 201280 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space